:max_bytes(150000):strip_icc()/GettyImages-2161043777-736a6f5483d147de9e399a37aea95e22.jpg?w=1920&resize=1920,1363&ssl=1 "Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket | Global News Avenue")
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2161043777-736a6f5483d147de9e399a37aea95e22.jpg)
Key Points
- Novo Nordisk lowered the price of its weight loss medication to $499 per month, some of which are in patients with change.
- The deal is available through the drugmaker’s new NovoCare Pharmacy product.
- Eli Lilly took a similar move last month, reducing the cost of weight loss medications for some out-of-pocket patients.
Novo Nordisk(NGOs) is lowering the price of its popular weight loss drug Wegovy.
Novo Nordisk said Wegovy is now getting $499 per month through all dose levels of Novocare Pharmacy, a new direct delivery service for the drug. This offer is for patients without insurance or for patients with commercial insurance that does not include obesity medications. According to the company’s website, patients could previously buy the drug for $650 a month.
This is the latest move Food and Drug Administration decision The active ingredients in other weight loss treatments of Wegovy and Novo Nordisk are no longer considered short of. Last month, rival drugmaker Eli Lilly (Lai) return Reduced price Its popular weight loss medications for self-paying patients’ heels Similar FDA rulings.
Between them, Novo Nordisk and Eli Lilly Domination Goldman Sachs analysts reportedly said the weight loss market could To reach $130 billion By 2030.
Novo Nordisk shares were close to 4% intraday trading on Wednesday, but lost about a quarter of its value in the past 12 months.
Correction – March 5, 2025: This article has been corrected to reflect the announcement made by Novo Nordisk on Wednesday.
:max_bytes(150000):strip_icc()/GettyImages-2161043777-736a6f5483d147de9e399a37aea95e22.jpg?w=1200&resize=1200,0&ssl=1&description=Novo+Nordisk+Drops+Price+of+Weight-Loss+Drug+Wegovy+for+Some+Patients+Paying+Out+of+Pocket+%7C+Global+News+Avenue){kind=link}